STOCK TITAN

Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company, will present at the H.C. Wainwright Bioconnect Virtual Conference. The pre-recorded presentation is set for January 10th at 7:00 am ET, accessible via the company’s website. Established in 2015, Aziyo focuses on innovative products to enhance surgical outcomes, particularly for patients with implantable medical devices. Their extensive portfolio includes commercial-stage offerings across cardiovascular, orthopedic, and reconstructive specialties.

Positive
  • None.
Negative
  • None.

SILVER SPRING, Md., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that members of management will present at the upcoming H.C. Wainwright Bioconnect Virtual Conference.

A Pre-recorded presentation will be available on Monday, January 10th at 7:00 am Eastern Time. Interested parties may access a webcast of the presentation on the investor section of the Company’s website at www.Aziyo.com

About Aziyo Biologics
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.        

Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com

Investors:
Leigh Salvo
Gilmartin Group
investors@aziyo.com


FAQ

What will Aziyo Biologics present at the H.C. Wainwright Bioconnect Virtual Conference?

Aziyo Biologics will present a pre-recorded session discussing their innovative regenerative medicine products on January 10th, 2022.

When is Aziyo Biologics' presentation scheduled?

Aziyo Biologics' presentation is scheduled for January 10th, 2022, at 7:00 am Eastern Time.

How can I access Aziyo Biologics' presentation?

The presentation can be accessed through the investor section of Aziyo Biologics' website.

What is Aziyo Biologics focusing on in their product development?

Aziyo Biologics concentrates on creating next-generation products to improve outcomes for patients undergoing surgery, primarily those receiving implantable medical devices.

When was Aziyo Biologics founded?

Aziyo Biologics was founded in 2015.

What specialties does Aziyo Biologics' product portfolio cover?

Aziyo Biologics' product portfolio includes offerings for cardiovascular, orthopedic, and reconstructive specialties.

Elutia Inc.

:AZYO

AZYO Rankings

AZYO Latest News

AZYO Stock Data

24.21M
4.12M
2.18%
70.44%
0.42%
Medical Devices
Healthcare
Link
United States
Silver Spring